[HTML][HTML] The effectiveness of hyaluronic acid in reducing adverse effects associated with inhaled hypertonic saline therapy in patients with cystic fibrosis: A systematic …
S Arshid, SE Ullah, J Imran, MA Syed… - Canadian Journal of …, 2023 - ncbi.nlm.nih.gov
Background Inhaled hypertonic saline (HS) is an effective mucolytic agent in patients with
cystic fibrosis (CF). However, adverse events can impair the clinical utility of hypertonic …
cystic fibrosis (CF). However, adverse events can impair the clinical utility of hypertonic …
[HTML][HTML] Making respiratory care safe for neonatal and paediatric intensive care unit staff: mitigation strategies and use of filters
BG Carter, E Harcourt, A Harris, M Zampetti… - Canadian Journal of …, 2024 - ncbi.nlm.nih.gov
Background Many medical devices in pediatric and newborn intensive care units can
potentially expose healthcare workers (HCWs) and others to transmission of respiratory and …
potentially expose healthcare workers (HCWs) and others to transmission of respiratory and …